So Ran Hong, M.D.
Novum Pharmaceutical Research Services
14
14
14
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+8 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (14)
Showing 10 of 14 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
loic MONDOLONI
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Sabine Hazan, MD
ProgenaBiome
Shared therapeutic areas:
Robert B Innis, M.D.
National Institute of Mental Health (NIMH)
Shared therapeutic areas:
Mikhail Samsonov
R-Pharm
Shared therapeutic areas:
Hamid Gourabi, PhD
head of Royan Institute
Shared therapeutic areas:
emilie garrido pradalie
APHM
Shared therapeutic areas:
Waqar ahmed awan, Phd
Riphah International University
Shared therapeutic areas:
Murad Alam, MD
Northwestern University
Shared therapeutic areas:
Alan Kivitz, MD
Altoona Center for Clinical Research
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (14)
Showing 14 of 14 trials
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions
Food Study of Cetirizine HCl Tablets 10 mg and Zyrtec® 10 mg
Fasting Study of Cetirizine HCl Tablets 10 mg and Zyrtec® Tablets 10 mg
Bioequivalency Study of Zaleplon 10 mg Capsules Under Fasting Conditions
Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed Conditions
The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed Conditions
To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions
To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Fasting Conditions
To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions
All 14 trials loaded